Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Other Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: L-THYROXIN [LEVOTHYROXINE SODIUM]
Diagnostic Lab Data:
CDC 'Split Type': DEPFIZER INC2021645035
Write-up: hallucination; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 30May2021 (at the age of 38-year-old) as 1st dose, single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication included levothyroxine sodium (L-THYROXIN [LEVOTHYROXINE SODIUM]). The patient experienced hallucination two days after vaccination (01Jun2021). The outcome of the event was unknown. Information on the lot/batch number has been requested.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166